Nrx Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nrx Pharmaceuticals Inc's ROI in the second quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Nrx Pharmaceuticals Inc 's return on investment (ROI) in its second quarter of 2026

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	0	-13	-16	-26	-36
Return On Investment (TTM)	165.76 %	-	-	-	-
NRXP's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-22	-24	-29	-39	-35

NRXP Company Profile >> Back to NRXP Roi Comparisons >> See Annual NRXP Return On Investment

Return On Investment NRXP's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Nrx Pharmaceuticals Inc's II. Quarter Investments	$ 0 Millions	NRXP's Balance sheet
Nrx Pharmaceuticals Inc's II. Quarter Income	$ -17 Millions	Quarterly NRXP's Income Statement
NRXP's Income by Division		See NRXP's Income by Division

NRXP Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	-16	-18	-12	10	21
Y / Y Investment Growth	-	-	-	-50.83 %	-
Net Income in Millions	-29	-25	-30	-40	-349
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-388.56 %	-1676.85 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NRXP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NRXP's Competitors
Subscribers only: Roi for Nrx Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for NRXP's Customers

Other Ratios
NRXP's Roa	NRXP's Inventory Turnover Ratio	NRXP's Growth Rates	NRXP's Dividend Statistics
	NRXP's Profitability Ratios	NRXP's Asset Turnover Ratio	NRXP's Dividend Growth
NRXP's Roe	NRXP's Valuation Ratios	NRXP's Financial Strength Ratios	NRXP's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Omeros Corporation	198.34 %
Elutia Inc	191.75 %
Sanuwave Health Inc	167.92 %
Vor Biopharma Inc	162.71 %
Capforce Inc	161.42 %
Kyntra Bio Inc	157.74 %
Silexion Therapeutics Corp	127.60 %
Quince Therapeutics Inc	112.49 %
Pulmatrix Inc	108.83 %
Interpace Biosciences Inc	100.71 %
Arbutus Biopharma Corp	99.18 %
Rigel Pharmaceuticals Inc	89.00 %
Oncotelic Therapeutics Inc	87.35 %
Actinium Pharmaceuticals Inc	84.38 %
Exelixis Inc	82.05 %
Lensar Inc	75.31 %
Ironwood Pharmaceuticals inc	70.54 %
Oramed Pharmaceuticals Inc	68.90 %
Indivior Pharmaceuticals Inc	68.79 %
Rallybio Corporation	68.28 %
Fortress Biotech Inc	68.27 %
Earth Science Tech Inc	64.38 %
Meiragtx Holdings Plc	55.83 %
Elite Pharmaceuticals Inc	53.48 %
Idexx Laboratories Inc	51.80 %
Aurinia Pharmaceuticals Inc	50.35 %
Qhslab Inc	48.94 %
Q32 Bio Inc	47.43 %
Vaxart Inc	46.17 %
Liquidia Corporation	42.09 %

Date modified: 2026-09-26T07:39:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.